What the business is, and whether it's a good one at a fair price.
Trades in food ingredients, edible oil and other commodities, with the bulk of disclosed segment revenue sitting in an "Others" line that is not broken out. The latest disclosed segment split (year-to-date period ending 31 December 2018) puts Others at 57.4% of segment revenue, the Food & Ingredient Division at 29.6% and Edible Oil at 13.1%, with Securities, Manufacturing and Garment divisions contributing negligible amounts. Subsidiary Kavit Edible Oil Limited has been suspended since March 2015 and carries a negative net worth. FY26 consolidated revenue was Rs. 110.275 crore with a net profit of Rs. 1.6213 crore, translating to a 2.6% EBITDA margin and a 1.47% net profit margin. Operating cash flow for FY26 was deeply negative at Rs. -2,348.34 lakhs, and the statutory auditor issued a qualified opinion flagging recoverability of Rs. 735.13 lakhs of loans and Rs. 2,943.89 lakhs of trade receivables. Cost structure as disclosed is dominated by employee cost at 1.4% of revenue and other operating expenses at 1.2% of revenue, with capex at 2.9% of revenue.
Measured from the filed financials, judged against its Trading - Chemicals peers · as of FY26 — not investment advice
How has the market priced it — with filings on the timeline?
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
How does it stack up on valuation, returns and growth?
Loading peers…
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Answered from EVEXIA LIFECARE LIMITED's filed financials and exchange disclosures
EVEXIA LIFECARE LIMITED is a Chemicals & Petrochemicals company listed on BSE.
Yes. Over the trailing twelve months EVEXIA LIFECARE LIMITED reported a net profit of ₹2 Cr on revenue of ₹110 Cr.
Not in the latest reported year — EVEXIA LIFECARE LIMITED's dividend payout for FY26 was nil.
Effectively yes. Debt stands at 0.01× equity.
On trailing P/E, EVEXIA LIFECARE LIMITED ranks 14 of 14 in Trading - Chemicals — cheaper than 0% of them, against an industry median of 17.2×. This is a position, not a valuation judgement.
On a typical session EVEXIA LIFECARE LIMITED moves 1.74% — that is the median absolute close-to-close move across its last 268 trading days. Announcement days are routinely larger.
Every NSE and BSE filing by EVEXIA LIFECARE LIMITED appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.
